Stock Option Exercise Disclosure - 409,080 Shares Exercised (1.12% Dilution)


  • Cumulative stock option exercises reached 409,080 shares (1.12% of total outstanding), triggering disclosure obligation
  • All exercised shares are newly issued; no treasury shares or cash settlement
  • Exercise date: 2026-04-06; Listing date: 2026-04-27
  • Key exercises: 44th tranche 1,720 shares (exercise price 44,900 won), 45th tranche 10,500 shares (47,650 won), 47th tranche 380 shares (46,100 won), 48th tranche 396,480 shares (36,350 won)
  • Exercise prices are at a premium to par value of 500 won, indicating in-the-money status
  • Remaining stock options: 187,850 shares (all new shares; settlement method subject to board decision upon exercise)

KOSDAQ Filing Information


  • Filing: Exercise of Stock Options
  • Company: LigaChem Biosciences (141080)
  • Submission: LigaChem Biosciences Inc.
  • Receipt: 04-08-2026
  • Under KRX KOSDAQ Market Division